KHDRBS1 Antibody (monoclonal) (M03)
Mouse monoclonal antibody raised against a partial recombinant KHDRBS1.
- 产品详情
- 实验流程
Application ![]()
| WB, IHC, IF, E |
---|---|
Primary Accession | Q07666 |
Other Accession | BC000717 |
Reactivity | Human |
Host | mouse |
Clonality | monoclonal |
Isotype | IgG2a Kappa |
Clone Names | 1A4 |
Calculated MW | 48227 Da |
Gene ID | 10657 |
---|---|
Other Names | KH domain-containing, RNA-binding, signal transduction-associated protein 1, GAP-associated tyrosine phosphoprotein p62, Src-associated in mitosis 68 kDa protein, Sam68, p21 Ras GTPase-activating protein-associated p62, p68, KHDRBS1 (HGNC:18116) |
Target/Specificity | KHDRBS1 (AAH00717, 176 a.a. ~ 275 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 IHC~~1:100~500 IF~~1:50~200 E~~N/A |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | KHDRBS1 Antibody (monoclonal) (M03) is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
REFERENCES
The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy. Pedrotti S, et al. EMBO J, 2010 Apr 7. PMID 20186123.Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients. Sellier C, et al. EMBO J, 2010 Apr 7. PMID 20186122.Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68. Paronetto MP, et al. Cancer Res, 2010 Jan 1. PMID 20028857.Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies. Rajan P, et al. BMC Cell Biol, 2009 Nov 13. PMID 19912651.Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma. Zhang Z, et al. Cancer Epidemiol Biomarkers Prev, 2009 Oct. PMID 19755649.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.